Ardea Biosciences competitive analysis

Explore Ardea Biosciences's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Last updated on: Aug 27, 2026
Patent NumberPublication DateTitleTotal Oppositions
Mar 21, 2018Treatment Of Gout And Hyperuricemia4
Apr 26, 2017Hypertension And Hyperuricemia2
Dec 14, 2016Polymorphic Forms Of 2-(5-Bromo-4-(4-Cyclopropylnaphthalen-1-Yl)-4H-1,2,4-Triazol-3-Ylthio) Acetic Acid And Uses Thereof2

Latest PTAB cases involving Ardea Biosciences

Discover the latest PTAB cases involving Ardea Biosciences, highlighting their recent legal challenges and patent disputes.

Peer Comparison New

IP litigation analysis comparing Ardea Biosciences with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Aug 27, 2026
CompanyOppositions FiledOppositions FacedPTAB Cases FiledPTAB Cases Faced
ARDEA BIOSCIENCES - 8 - -
ALFRED E TIEFENBACHER745 - -
BLLE DR19 - - -
STADA ARZNEIMITTEL14932 - -